UFP Technologies (UFPT) investor relations material

Company overview and capabilities

• Specializes in single-use and single-patient Medtech devices, with $600M revenue and 5,000 associates in 21 factories across five countries.

• Combines design engineering, materials expertise, and precision manufacturing to support product development and protection.

• Maintains strong vendor partnerships, often securing exclusive or semi-exclusive access to critical materials.

• Engages in rapid prototyping, custom equipment creation, and in-house tooling for quick design iterations.

• Quality systems are co-developed with customers, with many products 100% tested for patient safety.

Business model and customer relationships

• Operates a virtuous cycle where each project enhances expertise and deepens customer relationships.

• Focuses on long-term manufacturing contracts, with examples in robotic surgery, infection prevention, and patient safety.

• Forward integration and acquisitions expand capabilities and value to customers.

• Sole-source provider for several successful programs, leveraging redundant manufacturing facilities.

• Sub-markets like robotic surgery and patient services are experiencing double-digit growth.

Growth strategy and acquisitions

• Pursues a two-prong growth strategy: internal growth by focusing on the most profitable business segments and strategic acquisitions to add value.

• Acquisitions are guided by a technology roadmap developed with customer input, targeting new geographies and capabilities.

• Recent acquisitions have shifted revenue mix to $550M Medtech out of $600M total, tripling revenue in four years.

• Expanded global footprint with facilities in the U.S., Ireland, Mexico, Dominican Republic, and Costa Rica.

• Customer-funded development screens for serious partners and funds engineering resources.